Bepotastine Besilate Ophthalmic Solution 1.5% for Up to 8 Hours Following Dosing Reduces Total Non-Ocular Symptoms, Rhinorrhea, and Tearing in a Multi-Site Clinical Model of Allergic Conjunctivitis [PDF]
T.T. Macejko+8 more
openalex +1 more source
Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Patients with Allergic Conjunctivitis and Tear Film Dysfunction: A Randomized Controlled Trial. [PDF]
Troisi M+5 more
europepmc +1 more source
Association between keratoconus and allergic conjunctivitis in children attending a Tertiary Hospital in Nigeria. [PDF]
Balogun MM, Fashola MB.
europepmc +1 more source
Inhibitory effects of Tinospora cordifolia and Rubia cordifolia Linn. on egg albumin-induced experimental allergic conjunctivitis in rats [PDF]
Rishit Zalawadia+3 more
openalex +1 more source
Topical ketotifen treatment for allergic conjunctivitis: a systematic review and Meta-analysis. [PDF]
Dou XY, Zhang W.
europepmc +1 more source
Metabolic Biomarkers Mediate Allergic Conjunctivitis via Circulating Inflammatory Proteins: Evidence From a Mendelian Randomization Study. [PDF]
Cao X+5 more
europepmc +1 more source
Nonlinear effects of humidex on risk of outpatient visit for allergic conjunctivitis among children and adolescents in Shanghai, China: A time series analysis. [PDF]
Zhao H+7 more
europepmc +1 more source
Successful Transition From Topical Ophthalmic Drops to Cream Formulation in the Management of Mild Allergic Conjunctivitis: A Case Report. [PDF]
Nishio M+4 more
europepmc +1 more source